Patient who received custom gene therapy likely died from immune reaction, not CRISPR, paper says

Lei Lei Wu

News Reporter

Ryan Cross

Senior Science Correspondent

Researchers believe that Terry Horgan, a 27-year-old man with Duchenne muscular dystrophy who was the first person to receive a designer CRISPR therapy, died from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Patient who received custom gene therapy likely died from immune reaction, not CRISPR, paper says

Lei Lei Wu

News Reporter

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

Critical Junctures in Gene Therapy Clinical Material Manufacturing: Where Do I Start? And Will It Work?

Pa­tient who re­ceived cus­tom gene ther­a­py like­ly died from im­mune re­ac­tion, not CRISPR, pa­per says

News Reporter

Senior Science Correspondent

Sign up to read this article for free.

Patient who received custom gene therapy likely died from immune reaction, not CRISPR, paper says